Nippon Shikizai FY2026 Outlook: Guidance Points to Stronger Profit Recovery
Nippon Shikizai, Inc. (TSE:4920), a Japanese company specializing in the OEM production of cosmetics and over-the-counter pharmaceutical products with a focus on lipsticks and high-performance items, reported a challenging fiscal year ending February 2026, but management has raised optimistic guidance for the coming year.
Key Numbers (JPY in billions/millions)
| Metric | FY2026 (Actual) | YoY Change |
|---|---|---|
| Revenue | JPY 16.6bn | -5.6% |
| Operating Profit | JPY 180M | -63.2% |
| Ordinary Income | JPY 151M | -58.6% |
| Net Profit | JPY 335M | +55.1% |
| Operating Margin | 1.1% | — |
| Equity Ratio | 24.2% | — |
Business Overview Nippon Shikizai operates in the cosmetics and pharmaceutical sectors, leveraging its OEM production model and a strong presence in high-end products such as lipsticks. The company also has a subsidiary in France, which may contribute to its strategic positioning in international markets.
Analysis The company’s FY2026 results reflect a significant decline in revenue and operating profit, with the latter falling by 63.2% year-over-year. This sharp drop in operating profit is particularly concerning, as the operating margin of 1.1% is well below the industry average of 6.0%, indicating a substantial deterioration in core business profitability.
Despite the decline in operating and ordinary income, net profit increased by 55.1% compared to the previous year. This divergence highlights the potential influence of non-operating factors, such as cost management improvements or contributions from the French subsidiary. However, investors should be cautious, as the increase in net profit may not be fully attributable to core business performance and could include one-time or non-recurring gains.
The company’s FY2026 results are also marked by a slight increase in the equity ratio to 24.2% from 22.5%, suggesting a more conservative capital structure and potentially improved financial resilience.
Next Year Guidance Management has provided forward-looking guidance for the next fiscal year, with the following targets:
| Metric | FY2027 (Forecast) | YoY Change vs. FY2026 |
|---|---|---|
| Revenue | JPY 18.36bn | +10.3% |
| Operating Profit | JPY 394M | +118.9% |
| Ordinary Income | JPY 81M | +187% |
| Net Profit | JPY 275M | +187% |
Revenue target: JPY 18.36bn (+10.3% YoY) — in-line with industry expectations; the operating profit target implies a significant margin recovery, suggesting improved cost control and potential demand rebound.